Pertussis (Whooping Cough) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 70 pages | ID: P71636B01DECEN
VPAResearch

Abstracts

Pertussis (Whooping Cough) Drug pipeline report- 2020 is an annual R&D review of Pertussis (Whooping Cough) pipeline candidates. The report presents the current status of all major Pertussis (Whooping Cough) therapeutic compounds. Detailed insights into Pertussis (Whooping Cough) pipeline development, current status, companies, drug profiles and Pertussis (Whooping Cough) preclinical and clinical trials are included.

2020 Pertussis (Whooping Cough) Pipeline Market Insights
Pertussis (Whooping Cough) disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Pertussis (Whooping Cough) therapies, pipeline by phase and others are included.

Pertussis (Whooping Cough) pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Pertussis (Whooping Cough) Therapeutic Drug candidates
Both active and inactive Pertussis (Whooping Cough) pipeline drug candidates are included in the report

Pertussis (Whooping Cough) Clinical Trials and preclinical Studies
Pertussis (Whooping Cough) In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Pertussis (Whooping Cough) pipeline market developments
Pertussis (Whooping Cough) Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Pertussis (Whooping Cough) pipeline companies in active development
The report analyzes Pertussis (Whooping Cough) pipeline of the below companies-

BIKEN Corp, Biological E Ltd, BioNet- Asia Co Ltd, BlueWillow Biologics, Boryung Pharmaceutical Co Ltd, Cadila Healthcare Ltd, DBV Technologies SA, GC Pharma, GlaxoSmithKline Plc, ILiAD Biotechnologies LLC, Indian Immunologicals Ltd, Olymvax Biopharmaceuticals Inc, Panacea Biotec Ltd, Sanofi, Serum Institute of India Ltd, Shantha Biotechnics Pvt Ltd, Synthetic Biologics Inc, Tianjin CanSino Biotechnology Inc, Wockhardt Ltd

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
19 Companies investing in Pertussis (Whooping Cough) pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Pertussis (Whooping Cough) pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. PERTUSSIS (WHOOPING COUGH) PIPELINE MARKET INSIGHTS, 2020

1.1 Pertussis (Whooping Cough) Disease Overview
1.2 Pertussis (Whooping Cough) Drug Pipeline Snapshot, 2020
  1.2.1 Pertussis (Whooping Cough) Pipeline Drugs by Phase
  1.2.2 Pertussis (Whooping Cough) Pipeline Drugs by Company
  1.2.3 Pertussis (Whooping Cough) Pipeline Drugs by Mechanism of Action
  1.2.4 Pertussis (Whooping Cough) Pipeline Drugs by Route of Administration

2. PERTUSSIS (WHOOPING COUGH) COMPANY WISE PIPELINE DETAILS

BIKEN Corp Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Biological E Ltd Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
BioNet- Asia Co Ltd Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
BlueWillow Biologics Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Boryung Pharmaceutical Co Ltd Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cadila Healthcare Ltd Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
DBV Technologies SA Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
GC Pharma Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
ILiAD Biotechnologies LLC Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Indian Immunologicals Ltd Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Olymvax Biopharmaceuticals Inc Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Panacea Biotec Ltd Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sanofi Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Serum Institute of India Ltd Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Shantha Biotechnics Pvt Ltd Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Synthetic Biologics Inc Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Tianjin CanSino Biotechnology Inc Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Wockhardt Ltd Pertussis (Whooping Cough) Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. PERTUSSIS (WHOOPING COUGH) DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. PERTUSSIS (WHOOPING COUGH) PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts